Fears over a drug that can be used to treat alcohol addiction are unfounded, according to its first ever systematic review, led by academics at The University of Manchester. Though the study found no evidence of any serious side-effects linked to Naltrexone, many doctors hold back from prescribing the drug, often citing liver toxicity as [...]
NICE has said that a new drug for preventing migraine is not a cost-effective use of NHS resources, in recently-published draft guidance. The guidance looks at Erenumab (also called Aimovig and made by Novartis) for preventing chronic and episodic migraine in adults who have four episodes or more of migraine every month, and where at [...]
As preparation for the 2019 Northern Ireland Pharmacy Conference forges ahead, ensure that you remain firmly in the know by checking out the recently-released itinerary. Taking place on 28th February 2019 at the Europa Hotel, Belfast, the Northern Ireland Pharmacy Conference will consider how all sectors of pharmacy might come together to use their current [...]
The US Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease. ‘The approval of Ultomiris will change the way that patients with PNH are treated,’ explained Richard Pazdur, MD, Director of the FDA’s Oncology Centre of Excellence, [...]
Responding to the publication of the NHS Long Term Plan, National Pharmacy Association Chief Executive, Mark Lyonette, has said, ‘People access NHS care in community pharmacies more frequently than they do any other part of the health service. So it is right that the plan states an aim to make more use of community pharmacies to [...]
Researchers recommend greater action to promote best practice as a new study has revealed a rise in prescriptions of opioids for treating chronic pain between 1998 and 2018. A review of opioid prescribing in the UK has shown that UK doctors are prescribing more and stronger opioid drugs to patients. The research showed a 34 [...]
